-
Budget Impact of Anakinra in Turkiye: An Analysis From the Social Security Institution’s Perspective
Sep 9, 2025, 16:22 PM -
Deep Brain Stimulation: A Cost-Saving Treatment Option for Extreme Treatment-Refractory Obsessive-Compulsive Disorder in the UK?
Sep 9, 2025, 16:22 PM -
Divergent Biologic Price Archetypes: Year-on-Year List Price Evolution Pre- and Post-Biosimilar Entry in the US, Europe, and Japan
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Noninvasive Tests Strategies for Metabolic Dysfunction-Associated Steatohepatitis (MASH) Diagnosis in Japan
Sep 9, 2025, 16:22 PM -
Delphi Panel for Standardizing Outcome Measures in Radical Prostatectomy Surgical Care Pathway
Sep 9, 2025, 16:22 PM -
Medicare Reimbursements Following Confirmatory MRI-Guided Biopsy vs. Systematic Biopsy Only in Low-Risk and Favorable Intermediate-Risk Prostate Cancer: A Real-World Cost Analysis Among Elderly Medicare Beneficiaries
Sep 9, 2025, 16:22 PM -
Evaluating an Automated AI-Driven Pipeline for Literature Surveillance and Synthesis: A Proof-of-Concept for Health Economics and Outcomes Research (HEOR) Communications
Sep 9, 2025, 16:22 PM -
Impact of Indirect Treatment Comparison (ITC) Methodology on Cost-Effectiveness of Quizartinib in Acute Myeloid Leukemia (AML) in Canada and the United Kingdom (UK)
Sep 9, 2025, 16:22 PM -
Provisional Listing of Digital Healthcare Applications Digas Improves Patients' Access to Healthcare in Germany
Sep 9, 2025, 16:22 PM -
Safety Profile of Semaglutide in Obesity Management With or Without Type 2 Diabetes (T2DM): A Systematic Literature Review From Controlled and Real-World Settings
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Entrectinib in First-Line Treatment for NTRK Locally Advanced or Metastatic NSCLC in China
Sep 9, 2025, 16:22 PM -
Site-Specific Wastewater-Based Surveillance in Early Detection of COVID-19 New Cases and Prediction of Mass Testing Outcomes in Long-Term Care Facilities
Sep 9, 2025, 16:22 PM -
Prefilled Syringes in Anesthesiology: A Quantitative Assessment of Economic and Organizational Outcomes
Sep 9, 2025, 16:22 PM -
Clinical and Economic Factors Underlying QALY Weights and Severity Modifiers in NICE Health Technology Evaluations: An Analysis of Recent Appraisals
Sep 9, 2025, 16:22 PM -
Overall Survival With Second-Generation Androgen-Receptor Signaling Inhibitors in Patients With Metastatic Castration Resistant Prostate Cancer: An Umbrella Review
Sep 9, 2025, 16:22 PM -
Detection of a Novel Safety Signal for Atorvastatin Potential Association With Hilar Lymphadenopathy Using FAERS Disproportionality Analysis and Molecular Docking
Sep 9, 2025, 16:22 PM -
Exploring the Use and Perception of Patient-Reported Outcome Evidence Among Cardiologists and Patients With Heart Failure
Sep 9, 2025, 16:22 PM -
What Counts? Exploring Stakeholder Perspectives on the Value of Guiding Criteria for Prioritizing Public Funding of Health Technologies
Sep 9, 2025, 16:22 PM -
Clinical Evidence Quality in Appraisals of Drugs for Rare Diseases in England and Germany
Sep 9, 2025, 16:22 PM -
Automation-Only Is NOT AI: Beware, HEOR Colleagues
Sep 9, 2025, 16:22 PM
